Overview
FrançaisABSTRACT
The substitution of raw materials from the petrochemical industry has been initiated in many industrial sectors to deal with limited resources and meet consumers' needs for natural products. This eco-responsible approach of the valorization of vegetable raw materials is booming in the pharmaceutical industry. The article focuses on two main families of green excipients: the potential of vegetable lipids in new biopharmaceutical or technological functions and the use of native or modified vegetable proteins in conventional or innovative pharmaceutical forms.
Read this article from a comprehensive knowledge base, updated and supplemented with articles reviewed by scientific committees.
Read the articleAUTHORS
-
Sophie GIROD FULLANA: Professor at the University of Toulouse III Paul Sabatier - Faculty of Pharmaceutical Sciences - CIRIMAT, Toulouse, France
-
Anne AUBERT-POUESSEL: Senior lecturer at the University of Montpellier - UFR of Pharmaceutical and Biological Sciences, - Institut Charles Gerhardt Montpellier (ICGM), Montpellier, France
INTRODUCTION
Excipients are substances or mixtures of substances used in the formulation of a drug. Defined as being inert with respect to the active ingredient, and not inducing any undesirable effects in the patient (with the exception of excipients with notorious effects), they are chosen for technological reasons (to stabilize, facilitate flow, improve taste...) or biopharmaceutical reasons (to solubilize, modulate release...). These raw materials, essential for the formulating pharmacist, are governed by legislation and listed in the European Pharmacopoeia.
Excipients come from a variety of sources: mineral or organic, synthetic or natural. Excipients of natural origin have been used since the beginnings of formulation in the 2nd century. Some were extracted from plants: vegetable oils, starches, etc. With industrialization in the 19th century, some were replaced by synthetic or hemisynthetic excipients derived from petrochemicals: mineral oils, silicones, modified celluloses, etc. But environmental concerns have led to a renewed interest in raw materials of natural origin that are more respectful of the environment. The agri-food and cosmetics formulation sectors were the first to be affected, and the changes they triggered led to the emergence of raw materials whose potential in the pharmaceutical field now needs to be assessed and developed to meet pharmaceutical requirements.
Plant-derived excipients offer a number of advantages: firstly, their abundance on land or in the oceans, and secondly, their safety. They are virus-free, generally biocompatible and biodegradable, ensuring no accumulation in the body or the environment. Disadvantages include their purity, variable composition from batch to batch, the risk of bacterial contamination in the case of hydrated products, and the fact that certain excipients of plant origin can be allergenic (gluten, peanuts).
Excipients of plant origin have different chemical functions depending on their lipid, protein or polysaccharide nature. Their functions are manifold: gelling, emulsifying, coating, binding, solubilizing, etc. They can be classified into two categories: technological functions, which help with formulation or administration, and patient acceptability, and biopharmaceutical functions, which improve absorption of the active ingredient into the body and/or modulate its release rate. Whatever their role, excipients, often multiple within a single formulation, appear in all pharmaceutical forms: tablets and capsules, suppositories, solutions, emulsions, suspensions, aerosols, patches... These excipients must be safe, easily identifiable by conventional analytical techniques, and chemically inert to avoid interactions with other excipients, active ingredients and packaging.
...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
KEYWORDS
functionalisation | vegetable proteins | pharmaceutical formulation | biobased excipients | biobased lipids
This article is included in
Drugs and pharmaceuticals
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Emerging green excipients for the pharmaceutical industry
Bibliography
Regulations
European Pharmacopoeia 9th edition 9.8, 2019.
Handbook of pharmaceutical Excipients, 8 e edition, 2017. Published by Pharmaceutical Press and The American Pharmacists Association. Edited by P.J. Sheskey, W.G. Cook and C.G. Cable.
Patents (non-exhaustive list)
Lipid-based nanocarrier systems for using cancer treatment. GURSOY (R.N.), CEVIK (O.). European patent EP2790683 (2016).
Process for making protein delivery matrix and uses thereof. PAQUIN (P.), SUBIRADE (M.), BEAULIEU (L.). AU2002245979 (2002).
Modified protein excipient for delayed-release tablet. CAILLARD (R.), LECLERC (P.-L.), SUBIRADE (M.). US2011076326...
Directory
Suppliers – Distributors (non-exhaustive list)
Abitec, 501 W 1st Ave, Columbus, OH 43215, USA. Supplier of lipid-based pharmaceutical excipients.
BASF France SAS – Industrie et Service, 49, avenue Georges Pompidou, Levallois 92593. Production of specialty chemicals for most industries....
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference